Abstract

A prototype formula, which is amenable to Spheronization, was designed for the drug cores of Nitrofurantion. Effect of excipient variables and process variables to obtain a product giving desired drug release for a period of 8-10 hours was studied. The successful formulation was subjected to in vitro and in vivo evaluation and stability.